-
An Uncommon Partnership
Through the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.
by Ashley P. Taylor
-
Vaccinating Against Cancer
The human papillomavirus vaccine can significantly cut recipients' risk of several types of cancer. So why are vaccination rates relatively low in the U.S.?
by Brad Jones
-
Forward Look
FDA Acts to Curb Nicotine UseEfforts focus on cigarettes and new smokeless tobacco products.
by Brad Jones
-
Policy Matters
A Growing Commitment to Cancer SurvivorsThe number of cancer survivors is growing. We must step up efforts to meet their needs.
by Elizabeth M. Jaffee, MD
-
Get Involved
Helping Kids CopeHelp with Hope delivers care packages to young people whose mother or father has received a cancer diagnosis.
by Lindsey Konkel
-
Survivor Profile
The Power of PatientsJanet Freeman-Daily helps put patients at the center of lung cancer research.
by Robin Meadows
-
Raising Their Voices
People with metastatic breast cancer are demanding to be seen, counted and included in breast cancer research.
by Sue Rochman
-
Being Candid About Cancer
As a father with an aggressive brain cancer, I've opted against elaborate metaphors and in favor of candid speech when talking about cancer with my children.
by Adam Hayden
-
Sowing Seeds of Health
A program helps cancer survivors start gardens as a way to increase their vegetable consumption and physical activity.
by Ashley P. Taylor
-
What You Need to Know About DNA Testing
Before you order an at-home genetic testing kit, carefully consider the medical, psychological and legal implications.
by Tina Segura
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff